Teachers Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Teachers Advisors’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$342K	Buy	261,290 +75,839	+41%	+$94.3K	﹤0.01%	2676
2018 Q4	$169K	Sell	185,451 -26,519	-13%	-$40.6K	﹤0.01%	2879
2018 Q3	$436K	Buy	211,970 +35,336	+20%	+$74.2K	﹤0.01%	2688
2018 Q2	$318K	Hold	176,634	–	–	﹤0.01%	2850
2018 Q1	$416K	Hold	176,634	–	–	﹤0.01%	2611
2017 Q4	$332K	Hold	176,634	–	–	﹤0.01%	2747
2017 Q3	$439K	Buy	176,634 +27,278	+18%	+$67.6K	﹤0.01%	2645
2017 Q2	$412K	Buy	149,356 +12,003	+9%	+$33.5K	﹤0.01%	2689
2017 Q1	$415K	Buy	137,353 +19,792	+17%	+$56.2K	﹤0.01%	2623
2016 Q4	$371K	Hold	117,561	–	–	﹤0.01%	2690
2016 Q3	$401K	Buy	117,561 +11,280	+11%	+$31.2K	﹤0.01%	2583
2016 Q2	$243K	Buy	106,281 +13,960	+15%	+$34.2K	﹤0.01%	2794
2016 Q1	$232K	Sell	92,321 -7,755	-8%	-$17.3K	﹤0.01%	2741
2015 Q4	$331K	Buy	100,076 +9,165	+10%	+$27.4K	﹤0.01%	2642
2015 Q3	$220K	Hold	90,911	–	–	﹤0.01%	2843
2015 Q2	$266K	Buy	90,911 +3,269	+4%	+$12.7K	﹤0.01%	2889
2015 Q1	$352K	Hold	87,642	–	–	﹤0.01%	2634
2014 Q4	$264K	Hold	87,642	–	–	﹤0.01%	2782
2014 Q3	$222K	Hold	87,642	–	–	﹤0.01%	2832
2014 Q2	$216K	Buy	87,642 +21,236	+32%	+$48K	﹤0.01%	2901
2014 Q1	$176K	Hold	66,406	–	–	﹤0.01%	2922
2013 Q4	$193K	Hold	66,406	–	–	﹤0.01%	2876
2013 Q3	$204K	Buy	66,406 +6,795	+11%	+$21.5K	﹤0.01%	2800
2013 Q2	$191K	Buy	+59,611	New	+$191K	﹤0.01%	2789

Other funds holding LCTX

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.96B AUM 58.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Teachers Advisors's LCTX Position: Q1 2019 in Review

Teachers Advisors increased its Lineage Cell Therapeutics (LCTX) stake by 41% in Q1 2019, buying an estimated $94.3K and bringing the position to 261,290 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

Teachers Advisors first reported a position in LCTX in Q2 2013 and has held it in 24 quarters since. The position peaked at $439K in Q3 2017. 118 funds tracked by Wall St. Rank hold LCTX as of Q1 2019.

Teachers Advisors held 261,290 shares of Lineage Cell Therapeutics worth $342K as of Q1 2019.
Teachers Advisors bought 75,839 Lineage Cell Therapeutics shares in Q1 2019, an estimated $94.3K.
Lineage Cell Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2676 holding.
Teachers Advisors first reported a position in Lineage Cell Therapeutics in Q2 2013 and has held it in 24 quarters since.
Teachers Advisors's Lineage Cell Therapeutics position peaked at $439K in Q3 2017.
118 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.